Close
The page header's logo
Help
Login
Staff Login
Register
FR
0
Selected 
Invert selection
Deselect all
Deselect all
 Add to Cart
 Click here to refresh results
 Click here to refresh results
Go to Login page
 Hide details
doctype icon
Conceptually similar
Health Canada approves 1st pill to treat postpartum depression
play button
CP175458710 | Health Canada approves 1st pill to treat postpartum depression 
Newsroom Ready: Health Canada aims to speed COVID-19 vaccine approvals: Tam
play button
CP18981855 | Newsroom Ready: Health Canada aims to speed COVID-19 vaccine approvals: Tam 
Action button
Placeline/People
State Province Ontario
Country Canada

Newsroom Ready: Health Canada approves 1st pill to treat postpartum depression

Health Canada has approved the first drug designed to treat postpartum depression. Zuranolone, sold under the brand name Zurzuvae, is a pill taken once a day for 14 days and can start relieving depressive symptoms in as few as three days. Canadian Press reporter Nicole Ireland shares what experts have told her about the drug. (Dec. 9, 2025) 
Actions
 Add to collection
 Add to cart
Information
Source name: 
The Canadian Press
Unique identifier: CP175458568 
Legacy Identifier: r_Postpartum-Depression-Drug20251209T1655 
Type: Video 
Duration: 3m19s 
Dimensions: 1920px × 1080px     190.83 MB 
Usage rights: FOR ONE TIME USE ONLY. NO STORAGE FOR FUTURE USE. 
Create Date: 12/9/2025 4:55:00 PM 
Display aspect ratio: 16:9 
Tags
Depression
drug
health
Health Canada
life
medication
postpartum
postpartum depression
treatment